Investor List:

Top Pharmaceuticals Series A Investors in Canada (8)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Pharmaceuticals investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of James C. Murray, Partner at ExSight Capital Management
James C. Murray
Sweet spot: $1M
Range: $200K - $4.0M
Investors in Europe, Investors in Canada, Investors in United States
Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Series A), Investors in Therapeutics (Series B), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Diagnostics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Hardware (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Drug Delivery (Series B), Investors in Diagnostics (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in Hardware (Series B), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Pre-seed), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Pre-seed), Investors in Robotics (Pre-seed), Investors in Hardware (Pre-seed), Investors in Robotics (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Pre-seed), Investors in Health & Hospital Services (Seed), Investors in Digital Health (Seed), Investors in Diagnostics (Seed), Investors in Therapeutics (Series B), Investors in Robotics (Series B), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Hardware (Seed), Investors in Drug Delivery (Series B), Investors in Therapeutics (Pre-seed), Investors in BioTech (Series A), Investors in Robotics (Seed), Investors in Drug Delivery (Pre-seed), Investors in BioTech (Pre-seed), Investors in Drug Delivery (Series A), Investors in BioTech (Seed), Investors in Drug Delivery (Seed), Investors in Medical Devices (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Hardware (Series B), Investors in Pharmaceuticals (Series A), Investors in Robotics (Series B), Investors in Hardware (Pre-seed), Investors in Robotics (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Hardware (Series A), Investors in Digital Health (Series B), Investors in Robotics (Series A), Investors in Health & Hospital Services (Pre-seed), Investors in BioTech (Pre-seed), Investors in Hardware (Seed), Investors in Robotics (Seed), Investors in BioTech (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Canada (Other Lists), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in New York City (Other Lists)
Photo of Kunal Sethi, General Partner at Prithvi Ventures
Kunal Sethi
Prithvi Ventures·General Partner
Sweet spot: $1M
Range: $400K - $9.5M
Investors in Singapore, Investors in United Kingdom, Investors in Melbourne (Australia), Investors in Canada, Investors in United States, Investors in Europe
Investors in Medical Devices (Seed), Investors in Chemicals (Series A), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Series A), Investors in Chemicals (Seed), Investors in Drug Delivery (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in BioTech (Series A), Investors in AgTech (Series A), Investors in Drug Delivery (Seed), Investors in Pharmaceuticals (Series A), Investors in EnergyTech (Series A), Investors in Chemicals (Series A), Investors in DeepTech (Series A), Investors in EnergyTech (Seed), Investors in AgTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Drug Delivery (Series A), Investors in DeepTech (Seed), Investors in BioTech (Seed), Investors in Chemicals (Seed), Investors in Drug Delivery (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Series A), Investors in DeepTech (Series A), Investors in EnergyTech (Series A), Investors in AgTech (Series A), Investors in DeepTech (Seed), Investors in EnergyTech (Seed), Investors in AgTech (Seed), Investors in BioTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in BioTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Canada (Other Lists), Investors in Diverse Investors (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in New York City (Other Lists)
Photo of Xinhong Lim, Managing Director at Vickers Venture Partners
Xinhong Lim
Vickers Venture Partners·Managing Director
Sweet spot: $5.0M
Range: $3.0M - $10.0M
Investors in Singapore, Investors in United Kingdom, Investors in United States, Investors in China, Investors in Indonesia, Investors in Canada
Investors in Semiconductors (Series A), Investors in Chemicals (Series B), Investors in Semiconductors (Series B), Investors in Material Science (Series B), Investors in Chemicals (Series A), Investors in Material Science (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in EnergyTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Series B), Investors in Therapeutics (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Chemicals (Series B), Investors in EnergyTech (Series A), Investors in Therapeutics (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in BioTech (Series A), Investors in Chemicals (Series A), Investors in AI (Series B), Investors in Material Science (Series B), Investors in Semiconductors (Series B), Investors in AI (Series A), Investors in Medical Devices (Series B), Investors in Material Science (Series A), Investors in Semiconductors (Series A), Investors in Pharmaceuticals (Series B), Investors in EnergyTech (Series B), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in ClimateTech/CleanTech (Series B), Investors in EnergyTech (Series A), Investors in BioTech (Series B), Investors in ClimateTech/CleanTech (Series A), Investors in BioTech (Series A), Investors in AI (Series B), Investors in Canada (Other Lists), Investors in AI (Series A), Investors in Diverse Investors (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Jean-François Pariseau, Partner at Amplitude VC
Jean-François Pariseau
Amplitude VC·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Canada, Investors in Montreal
Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Series A), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Seed), Investors in Medical Devices (Series A), Investors in Impact (Series A), Investors in Digital Health (Seed), Investors in Impact (Seed), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health IT (Seed), Investors in BioTech (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in AI (Series A), Investors in AI (Seed), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Impact (Series A), Investors in Canada (Other Lists), Investors in Impact (Seed), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Diverse Investors (Other Lists), Investors in Investors who were founders (Other Lists), Investors in AI (Series A), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in AI (Seed)
Photo of Jeff Finkle, Managing Partner at Arcview Ventures
Jeff Finkle
Arcview Ventures·Managing Partner
Sweet spot: $150K
Range: $50K - $250K
Investors in United States, Investors in New York (NY), Investors in Israel, Investors in Canada
Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Retail (Series A), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Retail (Seed), Investors in Media/Content (Series A), Investors in Media/Content (Seed), Investors in Retail (Series A), Investors in AgTech (Series A), Investors in Media/Content (Series A), Investors in BioTech (Series A), Investors in Retail (Seed), Investors in Media/Content (Seed), Investors in AgTech (Seed), Investors in AgTech (Series A), Investors in BioTech (Seed), Investors in Consumer Internet (Series A), Investors in BioTech (Series A), Investors in AgTech (Seed), Investors in BioTech (Seed), Investors in Consumer Internet (Seed), Investors in AgTech (Series A), Investors in Pharmaceuticals (Seed), Investors in SaaS (Series A), Investors in Pharmaceuticals (Series A), Investors in AgTech (Seed), Investors in Consumer Internet (Series A), Investors in Consumer Internet (Seed), Investors in Retail (Series A), Investors in SaaS (Seed), Investors in SaaS (Series A), Investors in Retail (Seed), Investors in SaaS (Seed), Investors in Media/Content (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Media/Content (Seed), Investors in Pharmaceuticals (Series A), Investors in Canada (Other Lists), Investors in AgTech (Series A), Investors in Retail (Series A), Investors in SaaS (Series A), Investors in AgTech (Seed), Investors in SaaS (Seed), Investors in Consumer Internet (Series A), Investors in Retail (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Internet (Seed), Investors in Media/Content (Series A), Investors in Israel (Other Lists), Investors in Media/Content (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in SaaS (Series A), Investors in Consumer Internet (Series A), Investors in Consumer Internet (Seed), Investors in SaaS (Seed), Investors in New York City (Other Lists)
Photo of Eric Blondeel, Venture Partner at Pioneer Fund
Eric Blondeel
Pioneer Fund·Venture Partner
Sweet spot: $250K
Range: $200K - $300K
Investors in Canada
Investors in Diagnostics (Series B), Investors in Pharmaceuticals (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Digital Health (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Diagnostics (Series B), Investors in Canada (Other Lists), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Seed), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Digital Health (Seed), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed)
Photo of Samantha Tabone, Partner at Empath Ventures
Samantha Tabone
Sweet spot: $100K
Range: $50K - $250K
Investors in Canada, Investors in Australia, Investors in Europe, Investors in United Kingdom, Investors in United States
TP
Thomas (Tianyu) Piao
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Canada
Get new data & insights delivered to your inbox